SetPoint Medical makes the SetPoint System, an implanted vagus-nerve stimulator the FDA approved in July 2025 for adults with moderate-to-severe rheumatoid arthritis who do not respond to or cannot tolerate biologic drugs.
Develops minimally-invasive implanted muscle-machine (neuromuscular) interfaces for prosthetic and robotic control.
The Briefing, free: frontier tech in under 10 minutes, every morning, read or listened to. Yours to keep after the week.
30 sectors
One dashboard each, refreshed every day.
1,200+ companies
Funding, leadership, hiring, competitors.
Jobs board
Roles at companies LinkedIn never shows.
Video
What's hyped on 1,200+ official company channels.
Investors & exits
Who funds the frontier, and who bought what.
Frontline
The day's developments in every sector, scored.